MSN MoneyCentral - LOUISVILLE, Colo. and NEW YORK, Oct. 23 /PRNewswire-FirstCall/ — Replidyne, Inc. RDYN and Forest Laboratories, Inc. FRX , reported today the U.S. Food and Drug Administration (FDA) has issued a non- approvable letter for Replidyne’s new drug …